DEXCOM INC (1DXCM.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1DXCM - US2521311074 - Common Stock
60.31 EUR
-0.83 (-1.36%)
1DXCM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 67 industry peers in the Health Care Equipment & Supplies industry. While 1DXCM belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1DXCM is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, 1DXCM could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
- In the past year 1DXCM was profitable.
- In the past year 1DXCM had a positive cash flow from operations.
- Each year in the past 5 years 1DXCM has been profitable.
- In the past 5 years 1DXCM always reported a positive cash flow from operatings.
1.2 Ratios
- 1DXCM has a better Return On Assets (9.61%) than 86.57% of its industry peers.
- 1DXCM has a Return On Equity of 26.44%. This is amongst the best in the industry. 1DXCM outperforms 94.03% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 15.72%, 1DXCM belongs to the top of the industry, outperforming 94.03% of the companies in the same industry.
- 1DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is in line with the industry average of 9.84%.
- The last Return On Invested Capital (15.72%) for 1DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
- 1DXCM's Profit Margin of 15.96% is amongst the best of the industry. 1DXCM outperforms 88.06% of its industry peers.
- In the last couple of years the Profit Margin of 1DXCM has grown nicely.
- With a decent Operating Margin value of 18.41%, 1DXCM is doing good in the industry, outperforming 77.61% of the companies in the same industry.
- 1DXCM's Operating Margin has improved in the last couple of years.
- 1DXCM has a Gross Margin (60.20%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of 1DXCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1DXCM is creating some value.
- The number of shares outstanding for 1DXCM has been increased compared to 1 year ago.
- The number of shares outstanding for 1DXCM has been increased compared to 5 years ago.
- 1DXCM has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 5.16 indicates that 1DXCM is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.16, 1DXCM belongs to the top of the industry, outperforming 88.06% of the companies in the same industry.
- 1DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as 1DXCM would need 2.36 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 2.36, 1DXCM is in the better half of the industry, outperforming 74.63% of the companies in the same industry.
- A Debt/Equity ratio of 0.47 indicates that 1DXCM is not too dependend on debt financing.
- 1DXCM has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.16 |
ROIC/WACC1.64
WACC9.56%
2.3 Liquidity
- 1DXCM has a Current Ratio of 1.56. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.56, 1DXCM is in line with its industry, outperforming 47.76% of the companies in the same industry.
- A Quick Ratio of 1.38 indicates that 1DXCM should not have too much problems paying its short term obligations.
- The Quick ratio of 1DXCM (1.38) is better than 68.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- 1DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.41%, which is quite good.
- 1DXCM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.25% yearly.
- Looking at the last year, 1DXCM shows a quite strong growth in Revenue. The Revenue has grown by 14.21% in the last year.
- The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
- The Earnings Per Share is expected to grow by 22.40% on average over the next years. This is a very strong growth
- Based on estimates for the next years, 1DXCM will show a quite strong growth in Revenue. The Revenue will grow by 13.43% on average per year.
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.4%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.43%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 37.93 indicates a quite expensive valuation of 1DXCM.
- Compared to the rest of the industry, the Price/Earnings ratio of 1DXCM is on the same level as its industry peers.
- 1DXCM is valuated rather expensively when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
- 1DXCM is valuated quite expensively with a Price/Forward Earnings ratio of 27.86.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1DXCM is on the same level as its industry peers.
- 1DXCM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.93 | ||
| Fwd PE | 27.86 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1DXCM is on the same level as its industry peers.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1DXCM indicates a somewhat cheap valuation: 1DXCM is cheaper than 68.66% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.12 | ||
| EV/EBITDA | 23.64 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of 1DXCM may justify a higher PE ratio.
- A more expensive valuation may be justified as 1DXCM's earnings are expected to grow with 22.49% in the coming years.
PEG (NY)1.37
PEG (5Y)1.3
EPS Next 2Y24.04%
EPS Next 3Y22.49%
5. Dividend
5.1 Amount
- 1DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1DXCM (1/16/2026, 7:00:00 PM)
60.31
-0.83 (-1.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners97.73%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap23.65B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85
Price Target88.5 (46.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-4.53%
EPS NQ rev (3m)-6.46%
EPS NY rev (1m)0.59%
EPS NY rev (3m)1.85%
Revenue NQ rev (1m)-1.01%
Revenue NQ rev (3m)-2.76%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.93 | ||
| Fwd PE | 27.86 | ||
| P/S | 6.14 | ||
| P/FCF | 26.12 | ||
| P/OCF | 19.15 | ||
| P/B | 10.18 | ||
| P/tB | 10.57 | ||
| EV/EBITDA | 23.64 |
EPS(TTM)1.59
EY2.64%
EPS(NY)2.16
Fwd EY3.59%
FCF(TTM)2.31
FCFY3.83%
OCF(TTM)3.15
OCFY5.22%
SpS9.82
BVpS5.93
TBVpS5.7
PEG (NY)1.37
PEG (5Y)1.3
Graham Number14.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 5.16 |
F-Score5
WACC9.56%
ROIC/WACC1.64
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.4%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.43%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.12%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / 1DXCM.MI FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 4 / 10 to DEXCOM INC (1DXCM.MI). This can be considered as Fairly Valued.
What is the profitability of 1DXCM stock?
DEXCOM INC (1DXCM.MI) has a profitability rating of 8 / 10.
How financially healthy is DEXCOM INC?
The financial health rating of DEXCOM INC (1DXCM.MI) is 6 / 10.
Can you provide the expected EPS growth for 1DXCM stock?
The Earnings per Share (EPS) of DEXCOM INC (1DXCM.MI) is expected to grow by 27.59% in the next year.